CLASS III Drug recall · Reported 16 Sep 2015 · FDA Enforcement Report

Felodipine Extended-Release Tablets, 2.5 mg recalled

Mutual Pharmaceutical is recalling Felodipine Extended-Release Tablets, 2.5 mg, distributed nationwide in the US. The recall was initiated on 16 Jul 2015 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codeslot #s: 6669101 & 6669201, exp 12/15 and 6708201 & 6708301, exp 8/16
Quantity recalled25,272 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1420-2015
FDA event ID
71836
Recalling firm
Mutual Pharmaceutical, Philadelphia, PA
Classification
Class III
Status
Terminated
Recall initiated
16 Jul 2015
FDA classified
9 Sep 2015
Reported
16 Sep 2015
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

16 Jul 2015Recall initiated by company
9 Sep 2015Classified by FDA+55 days
16 Sep 2015Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Chemical Contamination; benzophenone leached from the product label varnish

Product as listed by the FDA

Felodipine Extended-Release Tablets, 2.5 mg, 100 count bottles, Rx only, Mutual Pharmaceutical Co. Inc., Philadelphia, PA --- NDC 53489-368-01

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Chemical Contamination; benzophenone leached from the product label varnish

Which lots are affected?

lot #s: 6669101 & 6669201, exp 12/15 and 6708201 & 6708301, exp 8/16

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

5 other products · FDA event 71836

More recalls from Mutual Pharmaceutical

All 14
ReportedClassRecallCompanyReasonWhere
DrugCLASS IISulfamethoxazole and Trimethoprim Tablets recalledMutual PharmaceuticalOtherMS
DrugCLASS IIIImipramine HCl Tablets, USP, 10 mg recalledMutual PharmaceuticalOtherNationwide
DrugCLASS IIIImipramine HCl Tablets, USP, 25 mg recalledMutual PharmaceuticalOtherNationwide
DrugCLASS IIIImipramine HCl Tablets, USP, 50 mg recalledMutual PharmaceuticalOtherNationwide
DrugCLASS IIIFelodipine Extended-Release Tablets, 5 mg recalledMutual PharmaceuticalOtherNationwide

Other Felodipine recalls

All 4
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIIFelodipine Extended Release Tablets, USP 10 mg recalledFelodipineHeritage PharmaceuticalsPotency & AssayNationwide
DrugCLASS IIIFelodipine Extended-Release Tablets, 5 mg recalledMutual PharmaceuticalOtherNationwide
DrugCLASS IIIFelodipine Extended-Release Tablets, 10 mg recalledMutual PharmaceuticalOtherNationwide